This page was machine-translated and may differ from the original. View original
Nexten showcases cardiovascular intervention robot at Asan International Medical Symposium
AI-based cardiovascular intervention robot prototype unveiled for the first time
Seeking future new growth drivers through entry into medical robot market as a new businessNexten is participating in the '2018 Asan International Medical Symposium' and will showcase its cardiovascular intervention robot product from the company's new medical robot business division.
The symposium, held under the theme of "Future Medicine Through Digital Healthcare Innovation," is being hosted by Seoul Asan Hospital and the Asan Institute for Life Sciences and will take place on the 15th.
At this event, which will be attended by domestic and international medical and healthcare companies as well as related institutions and academic figures, Nexten plans to introduce its newly developed AI-based cardiovascular intervention robot prototype through booth exhibitions.
Nexten, a specialist in CNC (Computer Numerical Control) automatic lathes, was selected as the lead organization for a government-funded robot core technology development project by the Ministry of Trade, Industry and Energy last year. The company established a medical robot business division and formed a consortium with renowned domestic and international research institutions including Seoul Asan Hospital, Seoul National University Hospital, Korea Advanced Institute of Science and Technology (KAIST), Korea Institute of Science and Technology (KIST), and Purdue University in the United States.
Virtual image of Nexten's three-dimensional visualization equipment
The company is developing an AI intervention robot system based on three-dimensional visualization (3D Mapping) technology for the heart and cardiovascular system, with a focus on technology development specialized in treating arrhythmias and various vascular diseases. The product being unveiled this time is a prototype intervention robot for arrhythmia treatment.
The cardiovascular intervention robot system being developed by Nexten and others utilizes a sensing catheter equipped with 64 electrodes to implement a three-dimensional map of the heart and cardiovascular system, and provides doctors with surgical plans and surgical pathways through an AI engine.
Compared to existing surgical methods, it is characterized by lower procedural difficulty and higher accuracy. Furthermore, the procedure time is expected to be significantly reduced, and the greatest advantage is the ability to reduce radiation exposure to both doctors and patients caused by CT imaging during the procedure.
Nexten CEO Jung Young-hwa emphasized, "By converging diverse technologies held by each company and institution, we will develop innovative medical robots and contribute to the health improvement of cardiovascular disease patients," and stressed that "the company will create future new growth drivers through strategic entry into the medical robot market."
To request a correction, reply or follow-up report on this article, see how to file a request. Previously published statements are collected in corrections & replies.

















